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Al~lrs~t Ras, a GTP-binding protein, converts membrane tyrosine kinase signalling to changes in gene expression patterns. Utilising a rat glucagon 
promoter-CAT construct (p[- 1.1]GLU-CAT) we demonstrate in transient transfection experiments that he oncogenic Ras inhibits cAMP-dependent 
activation of p[- 1.1 ]GLU-CAT in both glucagonoma InR l-G9 and insulinomafl-TC 1 cells. Conversely, the expression of a dominant negative mutant 
of Ras enhances the cAMP-induced activation of p[-1.1]GLU-CAT transcription i these cells. Our data suggests a functional interference of Ras 
with the cAMP-dependent transcription of the glucagon gene. 
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1. Introduction 
Ras proteins belong to a large family of low molecular weight 
guanine nucleotides binding proteins which exert diverse func- 
tions in various systems as, for example, growth promotion of 
NIH-3T3 cells, maturation of Xenopus laevis oocytes, and inhi- 
bition of coupling between receptors and ion channels in neu- 
rones. A universal function for Ras has been established in 
controlling cell growth and differentiation (for reviews ee [1-5]). 
Ultimately, to promote these actions, Ras regulates the tran- 
scription of selected genes by altering the activity of specific 
nuclear transcription factors [6,7]. The linkages between ex- 
tracellular stimuli, Ras, and the nucleus have been recently 
addressed. The intermediary role of a Grb2-mSos complex in 
tyrosine kinase receptor-triggered activation of Ras was de- 
scribed [8,9]. Furthermore, it was shown that Ras activation 
targets cRaf kinase to the plasma membrane which, in turn, 
switches on a series of ldnases including MAP kinase and MAP 
kinases (MAPKs) [10-12]. MAPKs translocate to the nucleus 
upon activation; many transcription factors contain potential 
MAPK phosphorylation sites. Furthermore, MAPK clearly 
plays a role in the activation of some transcription factors [13]. 
The relationships between Ras and cAMP-dependent signal 
transduction pathways are complex and not fully elucidated. In
yeast, Ras regulates adenylate cyclase [3,14]. The situation is 
not as clear in mammalian cells. Several data, although some- 
times discordant, indicate that Ras interacts with the cAMP- 
regulated pathway of gene transcription. Kedar et al. [15] and 
Galien et al. [16] described that Ras stimulates gene transcrip- 
tion through the cAMP Responsive Element (CRE). Sassone 
Corsi et al. [17] and Fukumoto et al. [18] reported exactly the 
contrary. There is data in pituitary and thyroid cell lines show- 
ing that Ras and PKA signalling pathways are mutually antag- 
onistic with respect to cell-specific transcriptional regulation of 
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endocrine genes [19-21]. On the other hand, Kupperman et al. 
[22] reported that in thyroid cells, Ras and PKA cooperate in 
the regulation of gene transcription. Moreover, conflicting data 
have also been published onthe relationships between Ras and 
PKC signalling pathways in regulating ene trancription. While 
Ras and PKC seem to cooperate in thyroid cells [20] they 
behave functionally antagonistic in GH4 neuroendocrine c lls 
[23]. 
Aim of our work was to elucidate the role of Ras in protein 
kinase A (PICA)- and protein kinase C (PKC)-stimulated glu- 
cagon gene transcription. The glucagon gene regulation has 
been recently focused on because of its significance in the 
hormonal control of fuel metabolism and particularly glucose 
homeostasis. In rodent islet cell lines, phorbol esters and ana- 
logs of diacylglycerol enhance glucagon biosynthesis [24] but a 
consensus DNA control element mediating phorbol ester effect 
on gene trancsription has not yet been identified in the glucagon 
gene 5'-flanking sequence. In contrast a perfect CRE was iden- 
tiffed within 300 bp of the transcriptional start site of the rat 
glucagon gene [25]. To analyse in detail some of the properties 
of the glucagon gene transcriptional regulation with the specific 
aim of learning more about the role of Ras, PKA, and PKC, 
we expressed either activated V-12 Ras or N-17 Ras dominant 
negative mutant in insulinoma nd glucagonoma cells utilising 
a glucagon promoter-CAT construct as reporter system, which 
is specifically inducible in these cells by PKA and PKC activa- 
tors (R.G., H.-C.F., A. Volz and B.G., unpublished results). 
2. Experimental 
2.1. Materials, plasmids, and cells 
Forskolin (FK) was from Sigma, phorbol-myristate, 12acetate 
(PMA) was from Fluka. Restriction endonucleases and DNA modifica- 
tion enzymes were f om Boehringer. p[-I. 1]GLU-CAT (containing the 
reporter gene CAT directed by ~ 1.1 kb of the glucagon gene 5'-flanking 
region) was previously described [26] and obtained from Dr. J. Habener 
(Boston, MA), pRSV-CAT (in which CAT reporter gene transcription 
is directed by the Rous sarcoma virus LTR) was obtained from Dr. M. 
Beato (Marburg, Germany) [27]. e-Ha-ras and V-12-ras cDNAs were 
kindly provided from Dr. E. Santos (Bethesda, MD) and Dr. H. Land 
(London, UK), respectively. Theexpression vector pMAM-neo was 
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obtained from Clontech. To construct the pMAM-V-12-ras expression 
vector, the V-12-ras cDNA was cloned into the multicloning site of
pMAM-neo. To obtain the dominant negative N-17 c-Ha-ras mutant, 
the eDNA of c-Ha-ras was mutagenized by a PCR-mediated strategy 
[28]. A point mutation (G--* A) in the second position of codon seven- 
teen was introduced and checked by sequencing [28]. The mutated 
eDNA was introduced into the multicloning site of pMAM-neo vector 
(obtaining the pMAM-N17-ras construct). Consequently to the muta- 
tion, an Asp residue (instead of a Ser residue) was present in the Ras 
protein at position 17. Cos7, SV40-transformed African green monkey 
kidney, FL, human ovary carcinoma, NCI H-64, human small-cell lung 
carcinoma, A431, human vulval epidermoid carcinoma, nd HIT-15, 
rat insulinoma cell lines were grown in DMEM supplemented with 10% 
Fetal Calf Serum (FCS) and 2 mM glutamine. InR1-G9, hamster 
glucagonoma cells were cultured in RPMI supplemented with 10% FCS 
and 2 mM glutamine, fl-TC1 mouse insulinoma cells were cultured in 
DMEM supplemented with 12.5% horse serum, 2.5% FCS, and 2 mM 
glutamine and were used for experiments between passages 19 and 28. 
2.2. TransfectDn and chloramphenicol-acetyltransferase (CAT) assay 
Cell transient ransfection in suspension (using the diethylami- 
noethyl-dextran method) and CAT assays were p rformed essentially 
as described by Gherzi et al. [29]. 
2.3. RNA isolation and Northern blot analysis 
Total RNA was prepared from cultured cells by the guanidine/cesium 
chloride method [28]. Total RNA (30 #g per lane) was denatured, 
electrophoresed and blotted to Hybond N+ nylon membranes as re- 
ported [30]. Filters were hybridised using radiolabeled c-Ha-ras and 
G3PDH (Clontech) c-DNA probes and washed as previously described 
[3Ol. 
3. R ~  
PKA and PKC activators increase glucagon gene transcrip- 
tion in insulinoma and glucagonoma cells ([24,25]; R.G., 
H.-C.F., A. Volz and B.G., unpublished results). Forskolin (4 
gM) ~ 2.5- and ~ 12-fold stimulates the p[-  1.1 ]GLU-CAT activity 
-~  c -Ha-ras  
- .~  G3PDH 
Fig. 1. Northern blot analysis of c-Ha-ras gene expression n cultured 
ceU lines. Northern blots of total RNA prepared from the indicated cell 
lines were hybridized with c-Ha-ras (upper panels) and G3PDH (lower 
panels) eDNA probes, washed, and autoradiographed. The figure 
shows representative autoradiograms (exposed 72 h at -80°C for c-Ha- 
ras or 4 h at -80°C for G3PDH) of two performed. A single blotwas 
subsequently h bridized with c-Ha-ras and G3PDH probes. 
Reporter Construct 
3' p[.l.1] GIuCAT 
I 
Effector Constructs 
MMTV LTR sv4o earty 
5' ~ IV-12 Ras I 3' pMAM V-12 Ras 
MMTV LTR sv4o early 
5' [ N 17 Ras ~ 3' pMAM N 17 tas  
Fig. 2. Schematic representation f plasmid vectors used in transient 
transfection experiments, p[-1.1]Glu-CAT that comprises approxi- 
mately 1.1 kb of the rat glucagon gene Y-flanking region linked to the 
CAT gene was used as the reporter construct, pMAM-V-12-ras and 
pMAM-N17-ras were obtained as detailed in section 2 and used, 
together with the pMAM-neo vector, as the effector constructs in tran- 
sient transfection experiments. 
in glucagon-producing I RI-G9 cells and in insulin-producing 
fl-TC1 cells, respectively. Furthermore, PMA (160 nM) en- 
hances p[-1.1]GLU-CAT activity through a cAMP-independ- 
ent pathway in both cell lines (~3-fold in InR1-G9, and ~6-fold 
in fl-TC 1) [RG]. Therefore, these cell lines are appropriate ools 
to investigate whether (and by which mechanism) Ras affects 
PKA- and PKC-induced gene transcription i endocrine cells. 
First, the expression levels of the Ha-ras gene were investi- 
gated in InR1-G9 and fl-TC1 cells using a full-length c-Ha-ras 
eDNA as probe for Northern blots. As shown in Fig. 1, fl-TC1 
and InR1-G9 express Ha-ras, the mRNA levels being ~6-fold 
higher in fl-TC1 than in InR1-G9. This data is supported by a 
previous report hat Ha-ras is expressed in rat pancreatic slets 
[31]. Out of five other cell lines analysed, only HIT-15 insuli- 
noma cells and NCI H-64 small lung carcinoma cells express 
Ha-ras (Fig. 1). Thus, to determine whether the endogenous 
Ha-ras signalling pathway is involved in either basal or acti- 
vated glucagon gene transcription, we performed transient co- 
transfection experiments using p[-1.1]GLU-CAT as the re- 
porter construct and a vector capable to express a dominant 
negative mutant of Ras (pMAM-N17-ras) [32,33] as the effec- 
tor (Fig. 2). The activity of our mutant was confirmed by 
evaluating its ability to inhibit the proliferation of transfeeted 
NIH-3T3 cells [32,33] (data not shown). Results presented in 
Fig. 3, demonstrate that transfection of pMAM-NlT-ras 
strongly enhances either basal (non-stimulated) or FK- and 
TPA-stimulated p[-1.1]GLU-CAT activity in InR1-G9 cells. 
Similar results, although smaller in magnitude, were obtained 
using fl-TC1 cells (data not shown). As a control, we co-trans- 
fected insulinoma cells with pMAM-N17-ras and pRSV-CAT. 
In both InR1-G9 and fl-TC1, pMAM-N17-ras does not affect 
pRSV-CAT activity (data not shown). These observations indi- 
cate that Ha-ras is involved in the control of glucagon gene 
transcription i  insulinoma cell lines. It is important o note 
that in all gene transfer experiments he total DNA transfected 
was fixed using 'non specific' pMAM-neo plasmid DNA. 
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pMAM N-17-ras - + -+ -+ 
--- 
Control Forskolin TPA 
Fig. 3. A Ras dominant negative mutant enhances p[-I.l]Glu-CAT 
activity in transfected InRIG cells. Subconfluent cultures of InRl-G9 
cells were transiently co-transfected with 12 ,ug of p[-l.l]Glu-CAT 
(reporter vector) and 12 pg of pMAM-neo (indicated as -) or of 
pMAM-Nl7-ras (indicated as +), respectively. 32hours later, cells were 
changed to serum-free medium in the absence or in the presence of 4 
PM forskolin or 160 nM TPA. After further 16 h, cells were harvested 
and CAT activity in cell lysates was measured. The average (k S.E.M.) 
of four independent experiments performed in duplicate is presented. 
To further investigate the role of p21-Ras in the regulation 
of glucagon gene transcription, we transfected InRl-G9 and 
j?-TCl cells with an expression vector coding for V-12-Ras 
(pMAM-V-12-ras) (Fig. 2) and measured the activity of the 
co-transfected p[-I.l]GLU-CAT. As depicted in Fig. 4, the 
basal activity of p[- l.l]GLU-CAT is not affected by the expres- 
sion of V-12-Ras. On the contrary, oncogenic Ras strongly 
reduces FK-stimulated CAT activity in both InRl-G9 and 
p-TCl cells (Fig. 4). Also the induction of p[-l.l]GLU-CAT 
activity by PMA is reduced in V-12-ras transfected cells, al- 
though in this case the effect of the activated oncogene is less 
pronounced (Fig. 4). The cotransfection of pMAM-V-12-ras 
does not affect the activity of pRSV-CAT in neither InRl-G9 
nor /I-TCI cells (data not shown). 
4. Discussion 
Glucagon gene expression is enhanced, at the transcriptional 
level, by PKA and PKC activators in a strictly cell-specific 
manner ([24,25]; R.G.). Despite the huge amount of investiga- 
tions published during the last few years, the mechanisms re- 
sponsible for the transduction of different extracellular stimuli 
to the nucleus are far from being completely elucidated. How- 
ever, the signal transduction pathways involving PKA, PKC, 
and Ras activation are supposed to play a crucial role in mod- 
ulating the expression and/or the activity of nuclear transcrip- 
tion factors responsible for gene transcription regulation [6,7J 
Recent experimental observations indicate that the stimula- 
tion of CAMP production and the activation of PKA inhibit 
proliferative signal transmission from Ras by preventing Ras- 
dependent activation of Raf-1 [34]. However, the relationship 
between PKA and Ras signal transduction pathways in regu- 
lating cell-specific gene transcription is still under discussion 
[l&22]. Our observations, the first in pancreatic endocrine 
cell lines, agree with data previously reported in pituitary cell 
lines [19-211. Our data indicates that the Ras and the PKA 
signalhng pathways are functionally antagonistic in regulating 
glucagon gene transcription in both glucagonoma and insuli- 
noma cell lines. 
Ras responsive elements (RRE) have been identified in the 
5’-regulatory regions of different genes [35]. The sequences of 
RREs are very close to the sequence of either CAMP responsive 
pMAMV-12-ms - + - + - + 
--- 
Control Forskolin TPA 
pMAMV-12-ras - + - + - + 
--- 
Control Forskolin TPA 
Fig. 4. The activated V12-ras reduces p[- 1 . l]Glu-CAT activity in trans- 
fected/%TCl and InRl-G9 cells. Subconfluent cultures ofj%TCl (panel 
A) and InRl-G9 (panel B) cells were transiently co-transfected with 
12 pg of p[-l.l]Glu-CAT (reporter vector) and 12 pg of pMAM- 
neo (indicated as -) or of pMAM-VlZ-ras (indicated as +), respectively. 
32 hours later, cells were changed to serum-free m dium in the absence 
or in the presence of 4 /cM Forskolin or 160 nM TPA. After further 
16 h, cells were harvested and CAT activity in cell lysates was measured. 
The average (k S.E.M.) of four independent experiments performed in
duplicate is presented. 
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element (CRE) or TPA responsive lement (TRE) [36]. Never- 
theless, the role of AP-1 and CREB transcription factors in 
mediating the transcriptional effects of Ras has not been yet 
fully elucidated [16]. A sequence analysis of the ~1.1 kb 
5'-flanking region of the rat glucagon gene (performed using 
the DNA Strider 1.2 software [37]) revealed the presence of a 
palindrome which comprises a canonical CRE at position 
-295/-288 [36]. This sequence differs for two bases from the 
sequence supposed to be the RRE in the fl-polymerase pro- 
moter [15]. Moreover, at position -252/-245 we identified the 
sequence 5'-CTGACTGA-Y which corresponds to the RRE 
present in the interleukin 2 promoter [35]. Ras was recently 
shown to be activated after insulin stimulation of various cells 
and it was concluded that Ras is possibly involved in insulin's 
signal transduction pathway [38,39]. Recently, we characterised 
insulin receptors in InR1-G9 cells and found that insulin inhib- 
its glucagon gene transcription i these cells [40]. Philippe sug- 
gested that this insulin effect is mediated via an 'insulin-re- 
sponse lement' localised in the A domain of the glucagon gene 
promoter G3 element [41]. This DNA region contains the RRE 
present in the interleukin 2 promoter. Furthermore, Philippe 
found two proteins that bind the 'insulin-response element' in 
a sequence-specific manner [41]. These two DNA-binding pro- 
teins are not A cell-specific since they are present also in nuclear 
extracts from JEG-3 chorioncarcinoma and HeLa cells [41]. 
Based on these and our present data it is possible to hypothesise 
that Ras mediates insulin-induced negative regulation on glu- 
cagon gene transcription. 
Activated Ras has been reported to act via both PKC-de- 
pendent and PKC-independent pathways [20,23]. Recently, 
Gutierrez-Hartmann a d co-workers [23] have demonstrated 
that Ras and PKC signalling pathways are separate and mutu- 
ally antagonistic n regulating rat prolactin promoter activity 
in GH 4 neuroendocrine c lls. Our evidence that, in endocrine 
pancreatic cell lines, a Ras dominant negative mutant strongly 
enhances glucagon gene promoter activity suggests that in en- 
docrine pancreatic cell lines Ras and PKC are also not cooper- 
ative. The relatively small effect of V-12-Ras expression  
PKC-stimulated glucagon gene transcription further supports 
the assumption that Ras and PKC are not synergistic n regulat- 
ing p[-1.1]GLU-CAT activity. 
In conclusion, in neuroendocrine c lls, the transcriptional 
regulation of specific genes eems to be controlled antagonisti- 
cally by PKA and Ras, respectively. This agrees with results 
provided by cell proliferation studies [34]. The relationships 
between PKC and Ras in specifically regulating neuroendo- 
crine genes transcription is complex as underscored by our 
results. 
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